Amplification of 1q21 occurs in approximately 30% of de novo and 70% of relapsed multiple myeloma (MM) and is correlated with disease progression and drug resistance. Here, we provide evidence that the 1q21 amplification-driven overexpression of ILF2 in MM promotes tolerance of genomic instability and drives resistance to DNA-damaging agents. Mechanistically, elevated ILF2 expression exerts resistance to genotoxic agents by modulating YB-1 nuclear localization and interaction with the splicing factor U2AF65, which promotes mRNA processing and the stabilization of transcripts involved in homologous recombination in response to DNA damage. The intimate link between 1q21-amplified ILF2 and the regulation of RNA splicing of DNA repair genes may be exploited to optimize the use of DNA-damaging agents in patients with high-risk MM. Marchesini et al. show that in multiple myeloma the overexpression of ILF2, resulting from chromosome 1q21 amplification, drives resistance to DNA-damaging agents partly by modulating the interaction between YB-1 and the splicing factor U2AF65 to promote the processing and stabilization of transcripts involved in homologous recombination.
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma / M. Marchesini, Y. Ogoti, E. Fiorini, A. Aktas Samur, L. Nezi, M. D'Anca, P. Storti, M.K. Samur, I. Ganan-Gomez, M.T. Fulciniti, N. Mistry, S. Jiang, N. Bao, V. Marchica, A. Neri, C. Bueso-Ramos, C. Wu, L. Zhang, H. Liang, X. Peng, N. Giuliani, G. Draetta, K. Clise-Dwyer, H. Kantarjian, N. Munshi, R. Orlowski, G. Garcia-Manero, R.A. Depinho, S. Colla. - In: CANCER CELL. - ISSN 1535-6108. - 32:1(2017 Jul), pp. 88-100.
Titolo: | ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma |
Autori: | |
Parole Chiave: | 1q21 amplification; DNA damage; DNA repair; ILF2; Multiple myeloma; splicing; oncology; cell biology; cancer research |
Settore Scientifico Disciplinare: | Settore MED/15 - Malattie del Sangue |
Data di pubblicazione: | lug-2017 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.ccell.2017.05.011 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Marchesini_Cancer Cell_2017.pdf | Publisher's version/PDF | Administrator Richiedi una copia |